. 2020 May 22;2020:5038217. doi: 10.1155/2020/5038217

Table 3.

The correlation between the SII and other clinicopathological parameters.

Variables	SII < 527 (cases)	SII ≥ 527 (cases)	p value
Total
Sex			0.062
Men	230	102
Women	110	70
Age (years)			0.414
<55	159	87
≥55	181	85
SRCC			0.384
mSRCC	298	146
pSRCC	42	26
Chemotherapy			0.352
Yes	167	77
No	173	95
Tumor size (cm)			<0.001
<4.75	175	53
≥4.75	165	119
pT			<0.001
T₁	74	10
T₂	45	19
T₃	39	23
T₄	182	120
pN			<0.001
N₀	127	39
N₁	60	26
N₂	67	33
N₃a	60	42
N₃b	26	32
pTNM			<0.001
I+II	173	47
III	167	125
Tumor location			0.079
Lower stomach	227	101
Middle stomach	49	26
Upper stomach	25	10
LM stomach	29	24
MU stomach	2	5
LMU stomach	8	6
Leukocyte			<0.001
<6.17	230	62
≥6.17	110	110
Neutrophil			<0.001
<3.27	231	29
≥3.27	109	143
Hemoglobin			<0.001
<121.2	60	80
≥121.2	280	92
Fibrinogen			<0.001
<3.06	204	64
≥3.06	136	108
Prealbumin			0.005
<234.5	149	98
≥234.5	191	74
Albumin			0.117
<42.5	187	82
≥42.5	153	90
Globulin			0.292
<29.9	278	147
≥29.9	62	25
PNI			<0.001
<48.73	92	84
≥48.73	248	88
Total gastrectomy			0.112
Yes	68	45
No	272	127
NLR			<0.001
<2.2	303	37
≥2.2	37	135

SII: systemic immune-inflammation index; SRCC: signet-ring cell carcinoma; pSRCC: pure signet-ring cell cancer; mSRCC: mixed signet-ring cell cancer; LM: lower and middle; MU: middle and upper; LMU: lower, middle, and upper; PNI: prognostic nutritional index; NLR: lymphocyte to neutrophil ratio.